Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
36,003,894
-
Share change
-
-1,070,712
-
Total reported value
-
$124,214,804
-
Put/Call ratio
-
36%
-
Price per share
-
$3.45
-
Number of holders
-
71
-
Value change
-
-$4,608,834
-
Number of buys
-
25
-
Number of sells
-
40
Institutional Holders of MOLECULAR TEMPLATES INC - COM (MTEM) as of Q1 2022
As of 31 Mar 2022,
MOLECULAR TEMPLATES INC - COM (MTEM) was held by
71 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,003,894 shares.
The largest 10 holders included
Bellevue Group AG, BVF INC/IL, PICTET ASSET MANAGEMENT SA, BlackRock Inc., VANGUARD GROUP INC, CAXTON CORP, Frazier Life Sciences Management, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., KINGDON CAPITAL MANAGEMENT, L.L.C., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
71
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.